On day 21 , a significantly higher proportion of infants in the L reuteri DSM 17938 group responded to treatment with a 50 % crying time reduction compared with infants given placebo ( 17 vs 6 , P = .035 ; relative risk , 3.3 ; 95 % CI , 1.55-7 .03 ) .